Taxoid XRP6258
Term · Oncology and biomedicine · MLC-T-ONC-008534
A drug used with prednisone to treat prostate cancer that has spread to other parts of the body and is castration resistant (has not responded to treatments that lower testosterone levels). It is used in patients who have already been treated with anticancer drugs that included docetaxel. It is also being studied in the treatment of other types of cancer. Taxoid XRP6258 stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called cabazitaxel and Jevtana.
| Identifier | MLC-T-ONC-008534 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cabazitaxel; Jevtana |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008534",
"term": "Taxoid XRP6258",
"field": "Oncology and biomedicine",
"definition": "A drug used with prednisone to treat prostate cancer that has spread to other parts of the body and is castration resistant (has not responded to treatments that lower testosterone levels). It is used in patients who have already been treated with anticancer drugs that included docetaxel. It is also being studied in the treatment of other types of cancer. Taxoid XRP6258 stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called cabazitaxel and Jevtana.",
"synonyms": [
"cabazitaxel",
"Jevtana"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/taxoid-xrp6258/"
}
Record 16,016 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.